Published in Obesity and Diabetes Week, July 11th, 2005
Diabetes patients in the study used Medtronic's Guardian RT Continuous Glucose Monitoring System to monitor glucose levels throughout the day and night. The system is designed to help patients reduce erratic blood sugar (glucose) fluctuations that can result in diabetes-related complications, including coma, blindness, kidney failure, amputation, impotence and heart disease.
During the 10-day pilot study, 16 patients responded to glucose values as well as high and low alerts displayed on the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.